Clinical Trial: Prognostic and Predictive Role of Intrinsic Molecular Subtypes in BRCA-associated Breast Cancer

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07617025) titled 'Prognostic and Predictive Role of Intrinsic Molecular Subtypes in BRCA-associated Breast Cancer' on April 21.

Brief Summary: This study is an observational study being carried out in several hospitals. No extra tests or procedures are required beyond those already part of normal medical care.

The study is sponsored by the University of Modena and Reggio Emilia and aims to include about 100 patients.

The main goal of the study is to better understand the different biological types of breast cancer in patients who have hormone receptor-positive (HR-positive), HER2-negative breast cancer related to BRCA gene mutations. In particular, ...